Gaudium IVF IPO Details, Dates, Price Band, Financials & Review

Gaudium IVF IPO is a book-built issue worth ₹165.00 crores, consisting of a fresh issue of ₹90.00 crores and an offer for sale of ₹75.00 crores. The IPO opens on February 20, 2026, and closes on February 24, 2026, with tentative listing on BSE and NSE on February 27, 2026.
The IPO is priced in the range of ₹75 to ₹79 per share, with a minimum investment of ₹14,931 for retail investors. Gaudium IVF & Women Health Ltd. operates in the fertility and reproductive healthcare segment, offering IVF and allied treatments across India.
Let us understand the Gaudium IVF IPO in detail.

Gaudium IVF IPO – Key Details

The following are some of the important and key details about the Gaudium IVF IPO.

Gaudium IVF IPO Timeline

The following table explains the tentative IPO schedule.

Gaudium IVF IPO Lot Size & Investment

The following table shows the minimum and maximum investment required.

About Gaudium IVF & Women Health Ltd. – Business Operations

Incorporated in March 2015, Gaudium IVF & Women Health Limited is engaged in providing In Vitro Fertilization (IVF) treatments across India. The company has expanded into multiple states using a hub-and-spoke operating model.
The company operates more than thirty locations, including seven hubs and twenty-eight spokes. It has also entered into strategic alliances with infertility experts to increase awareness around Assisted Reproductive Technology (ART) and IVF treatments.
Gaudium IVF serves patients from multiple international geographies, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.

Its centres are located across key Indian cities, including:

• Delhi (Janakpuri, Kailash Colony)
• Mumbai (Khar West)
• Ludhiana
• Srinagar
• Patna
• Bangalore
• Services Offered

Services Offered

The company provides specialized fertility and reproductive treatments, including:

• In Vitro Fertilization (IVF)
• Intracytoplasmic Sperm Injection (ICSI)
• Intrauterine Insemination (IUI)
• Ovulation induction

It also offers comprehensive gynaecological care for:

• PCOD / PCOS
• Endometriosis
• High-risk pregnancy management

Additionally, the company provides advanced male infertility treatments, including sperm retrieval procedures.

Competitive Strengths

The following are the key strengths of the company:

• Patient-centric treatment approach
• Experienced medical expert team
• Next-generation INTEGRA Ti labs for ICSI
• Highly technical USG-guided services
• Established hubs in prime urban locations including Mumbai, Bangalore, Delhi NCR, and Patna
• Asset-light business model

Gaudium IVF – Financial Performance

The following table shows restated consolidated financials:

Key Performance Indicators (KPI)

Objects of the Issue

The following explains how IPO proceeds will be used:

Valuation Snapshot

Market Capitalisation: ₹575.02 Cr
Promoter Holding: 99.99% (Pre-IPO) → 71.30% (Post-IPO)

IPO Reservation

Promoters

The promoters of the company are:

• Dr. Manika Khanna
• Dr. Peeyush Khanna
• Vishad Khanna

Summary

Gaudium IVF & Women Health Ltd. operates in the fertility treatment and reproductive healthcare segment, offering IVF and related services through a hub-and-spoke centre network across India. The company has expanded its presence across major cities and also caters to international patients.
The business model focuses on specialized fertility treatments, gynaecological care, and male infertility solutions supported by medical expertise and laboratory infrastructure. IPO proceeds are proposed to be utilized toward new centre expansion and loan repayment.

Also, we have a dedicated article on upcoming IPOs in february 2026, wherein you can check all the IPOs that were launched in february 2026 along with upcoming IPOs for february 2026.

Disclaimer

This content is for informational and educational purposes only and does not constitute investment advice. UnlistedKraft is not responsible for any losses arising from investment decisions based on this content. Readers should conduct their own research and consult qualified professionals before investing. IPO is expected to list on Feb 27, 2026, on BSE and NSE.

Frequently Asked Questions

What is the Gaudium IVF IPO?

Gaudium IVF IPO is a main-board IPO of ₹165.00 crore comprising fresh issue and offer for sale, priced at ₹75–₹79 per share.

When does the Gaudium IVF IPO open?

The IPO opens on February 20, 2026, and closes on February 24, 2026.

What is the lot size of Gaudium IVF IPO?

The minimum lot size is 189 shares.

When is Gaudium IVF IPO allotment?

The allotment is expected to be finalized on February 25, 2026.

When is Gaudium IVF IPO listing date?

The tentative listing date is February 27, 2026.

Who is the registrar of the Gaudium IVF IPO?

Bigshare Services Pvt. Ltd. is the registrar of the issue.

Author: Diwakar Singh

Diwakar Kumar Singh is a BFSI specialist and finance writer with over 7 years of hands-on experience in financial research, content creation, and analysis.

 

A Gold Medalist in MBA (Marketing) from IMT, he combines deep analytical skills with practical insights gained from evaluating companies, IPOs, unlisted shares, financial ratios, and investment opportunities. Diwakar has personally analysed hundreds of financial instruments and market scenarios, which he uses to break down complex topics into clear, actionable advice.

He has authored numerous in-depth finance articles, published multiple books internationally, and contributed to research publications. His work focuses on helping everyday investors and readers make better-informed financial decisions through well-researched, evidence-based explanations that are always grounded in real-world application rather than theory alone.